A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab in checkpoint inhibitor refractory advanced or unresectable melanoma

Shoushtari, A; Olszanski, A; Hornyak, T; Wolchok, J; Vetrhus, S; Handeland, KR; Kuryk, L; Jaderberg, M

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019; 7 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索